![Figure][1] A 53-year-old morbidly obese woman diagnosed with Crohn disease 3 years earlier was being treated with adalimumab (40 mg per 15 days) and methotrexate (15 mg per week). She… Click to show full abstract
![Figure][1] A 53-year-old morbidly obese woman diagnosed with Crohn disease 3 years earlier was being treated with adalimumab (40 mg per 15 days) and methotrexate (15 mg per week). She presented with severe fatigue and a 30-kg weight loss over the previous 2 months, as well as fever and
               
Click one of the above tabs to view related content.